Prospective Screening for Transthyretin Cardiac Amyloidosis In Spinal Stenosis Surgery Patients: Results of the CASS Study
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Is It Time for Population-Based Screening for Transthyretin Cardiac Amyloidosis?.
Goyal P, McDonald D JACC Adv. 2024; 3(10):101233.
PMID: 39290813 PMC: 11405786. DOI: 10.1016/j.jacadv.2024.101233.
References
1.
Eldhagen P, Berg S, Lund L, Sorensson P, Suhr O, Westermark P
. Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis. J Intern Med. 2020; 289(6):895-905.
PMC: 8248398.
DOI: 10.1111/joim.13222.
View
2.
Maurer M, Smiley D, Simsolo E, Remotti F, Bustamante A, Teruya S
. Analysis of lumbar spine stenosis specimens for identification of amyloid. J Am Geriatr Soc. 2022; 70(12):3538-3548.
PMC: 9771886.
DOI: 10.1111/jgs.17976.
View
3.
Godara A, Riesenburger R, Zhang D, Varga C, Fogaren T, Siddiqui N
. Association between spinal stenosis and wild-type ATTR amyloidosis. Amyloid. 2021; 28(4):226-233.
DOI: 10.1080/13506129.2021.1950681.
View
4.
Griffin J, Rosenthal J, Grodin J, Maurer M, Grogan M, Cheng R
. ATTR Amyloidosis: Current and Emerging Management Strategies: State-of-the-Art Review. JACC CardioOncol. 2021; 3(4):488-505.
PMC: 8543085.
DOI: 10.1016/j.jaccao.2021.06.006.
View
5.
Debonnaire P, Claeys M, De Smet M, Trenson S, Lycke M, Demeester C
. Trends in diagnosis, referral, red flag onset, patient profiles and natural outcome of de novo cardiac amyloidosis and their multidisciplinary implications. Acta Cardiol. 2021; 77(9):791-804.
DOI: 10.1080/00015385.2021.1976450.
View